179 related articles for article (PubMed ID: 16641890)
1. [Alzheimer's disease as neurodegenerative disorder].
Zabłocka A
Postepy Hig Med Dosw (Online); 2006; 60():209-16. PubMed ID: 16641890
[TBL] [Abstract][Full Text] [Related]
2. [Alzheimer's disease: new prospects in therapy and applied experimental models].
Kubis AM; Janusz M
Postepy Hig Med Dosw (Online); 2008 Aug; 62():372-92. PubMed ID: 18688208
[TBL] [Abstract][Full Text] [Related]
3. The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease.
Liu X; Hou D; Lin F; Luo J; Xie J; Wang Y; Tian Y
Rev Neurosci; 2019 Jul; 30(5):477-484. PubMed ID: 30530893
[TBL] [Abstract][Full Text] [Related]
4. [Pro-inflammatory cytokines in Alzheimer's disease].
Stamouli EC; Politis AM
Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
8. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.
Rojo LE; Fernández JA; Maccioni AA; Jimenez JM; Maccioni RB
Arch Med Res; 2008 Jan; 39(1):1-16. PubMed ID: 18067990
[TBL] [Abstract][Full Text] [Related]
10. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis.
D'Andrea MR; Nagele RG
Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465
[TBL] [Abstract][Full Text] [Related]
11. The involvement of the ubiquitin system in Alzheimer's disease (review).
Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
13. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
14. Protein disulfide isomerase P5-immunopositive inclusions in patients with Alzheimer's disease.
Honjo Y; Horibe T; Torisawa A; Ito H; Nakanishi A; Mori H; Komiya T; Takahashi R; Kawakami K
J Alzheimers Dis; 2014; 38(3):601-9. PubMed ID: 24037032
[TBL] [Abstract][Full Text] [Related]
15. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
16. Neuronal histamine and cognitive symptoms in Alzheimer's disease.
Zlomuzica A; Dere D; Binder S; De Souza Silva MA; Huston JP; Dere E
Neuropharmacology; 2016 Jul; 106():135-45. PubMed ID: 26025658
[TBL] [Abstract][Full Text] [Related]
17. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease.
Zhao M; Jiang XF; Zhang HQ; Sun JH; Pei H; Ma LN; Cao Y; Li H
Ageing Res Rev; 2021 Dec; 72():101483. PubMed ID: 34610479
[TBL] [Abstract][Full Text] [Related]
18. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches.
Ahmad MH; Fatima M; Mondal AC
J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in Alzheimer's disease--an update.
Shimohama S
Apoptosis; 2000 Feb; 5(1):9-16. PubMed ID: 11227497
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease pathogenesis and therapeutic interventions.
Parihar MS; Hemnani T
J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
